Apr 28th, 2026 How PT-141 Enhances Libido and Sexual Function PT-141 (bremelanotide) is an FDA-approved melanocortin receptor agonist that enhances sexual desire in premenopausal women with HSDD, with strong clinical evidence, though use in men remains off-label and less established
GHK-Cu (50 mg) Drives collagen synthesis, angiogenesis, and gene-level repair
In addition to its role in energy production, vitamin B12 is indispensable for the production of new protein
Oral Dosing Guide Because there are no human trials, there is no established human dose, schedule, or validated route for Dihexa
The Mexican National Nutrition Survey in 1999 showed a serum -tocopherol deficiency of nearly 30% in non-pregnant and pregnant women
According to the 2025 World Obesity Atlas, the number of obese people will increase by 115% (from 524 million to 1.13 billion) between 2010 and 2030